carvedilol has been researched along with guaifenesin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abuohashish, HM; Ahmed, MM; Al-Hosaini, KA; Al-Rejaie, SS; Fatani, AJ; Parmar, MY | 1 |
| Carrier, RL; Lerkvikarn, S; Lock, J; Nguyen, N; Semin, T; Yeap, YY | 1 |
1 review(s) available for carvedilol and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for carvedilol and guaifenesin
| Article | Year |
|---|---|
Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Carvedilol; Colitis, Ulcerative; Colon; Cytokines; Dinoprostone; Disease Models, Animal; DNA; Male; Malondialdehyde; Mucus; Nitric Oxide; Oxidative Stress; Propanolamines; Rats, Wistar; RNA; Sulfhydryl Compounds | 2015 |
Intestinal mucus is capable of stabilizing supersaturation of poorly water-soluble drugs.
Topics: Animals; Carvedilol; Cell Line, Tumor; Chemical Precipitation; Humans; Intestines; Mucins; Mucus; Piroxicam; Solubility; Swine; Water | 2019 |